483 Strides Pharma Science Aug 2018

483 Strides Pharma Science Aug 2018

Andrew Idzior FDA$119.00 - Available Now

FDA investigators audited the Strides Pharma Science - Bangalore, India facility and issued inspectional observations (via FDA 483) on 24 Aug 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 24 Aug 2018
  • Location: Bangalore, India
  • FEI: 3004554612
Add To Cart